Jerzy Bodurka to Kynurenic Acid
This is a "connection" page, showing publications Jerzy Bodurka has written about Kynurenic Acid.
Connection Strength
0.801
-
Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression. Brain Behav Immun. 2018 Jan; 67:59-64.
Score: 0.147
-
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav Immun. 2016 Aug; 56:335-42.
Score: 0.134
-
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Psychoneuroendocrinology. 2015 Dec; 62:54-8.
Score: 0.127
-
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun. 2015 May; 46:55-9.
Score: 0.123
-
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology. 2015 Feb; 52:200-11.
Score: 0.121
-
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology. 2015 Jan; 40(2):463-71.
Score: 0.118
-
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun. 2016 Mar; 53:39-48.
Score: 0.032